| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/23/1997 | EP0784753A1 Axial flow valve system for linear compressor |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784681A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 07/23/1997 | EP0784612A1 Urea derivatives and their use as acat-inhibitors |
| 07/23/1997 | EP0784429A1 Method and formulation of stimulating nitric oxide synthesis |
| 07/23/1997 | EP0641768B1 Nitroxyalkylamide derivative |
| 07/23/1997 | EP0581797B1 Novel thiophene-2-carboxylic acid derivatives and process for their production |
| 07/23/1997 | EP0538332B1 Polycyclic guanine derivatives |
| 07/23/1997 | CN1155285A New 3-substituted 3H-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 07/23/1997 | CN1155279A Neuroprotective 3-(piperidinyl-1)-chroman-4,7,-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 07/23/1997 | CN1155276A Enzyme inhibitors |
| 07/22/1997 | US5650524 Salt formation with tartaric acid and forming a clear solution |
| 07/22/1997 | US5650492 P-40 homodimer of interleukin-12 |
| 07/22/1997 | US5650447 Nitric oxide-releasing polymers to treat restenosis and related disorders |
| 07/22/1997 | US5650429 Use of DL-(+/-)-α-lipoic acid, D-(+)-α-lipoic acid, α-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/22/1997 | US5650424 Antiagglomerants using imidazolidindiones |
| 07/22/1997 | US5650420 Pramipexole as a neuroprotective agent |
| 07/22/1997 | US5650414 Pyrazolopyridines or imidazolopyridines |
| 07/22/1997 | US5650408 Thiazolo benzazepine containing dual action inhibitors |
| 07/22/1997 | US5650280 Cellubrevin homolog |
| 07/22/1997 | CA2024310C Method of producing cholesterol-free egg products with an extended refrigerated shelf life and products produced thereby |
| 07/17/1997 | WO1997025440A2 Methods and compositions for diagnosis of hyperhomocysteinemia |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025418A1 Angiotensin converting enzyme inhibitors |
| 07/17/1997 | WO1997025343A2 Antithrombotic agents and methods of use |
| 07/17/1997 | WO1997025333A2 Macrocyclic compounds made from suboxide units |
| 07/17/1997 | WO1997025331A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | WO1997025323A1 Fibrinogen receptor antagonists |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025051A1 Oral administration of effective amounts of forms of hyaluronic acid |
| 07/17/1997 | WO1997025048A1 Novel cycloalkyl substituted imidazoles |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025045A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025043A1 A method of treating hypercholesterolemia and related disorders |
| 07/17/1997 | WO1997025042A1 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | DE19601303A1 Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln Novel benzoylguanidine derivatives, processes for their preparation and their use in the preparation of medicaments |
| 07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
| 07/17/1997 | CA2242609A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | CA2242385A1 Antithrombotic agents and methods of use |
| 07/17/1997 | CA2242327A1 Novel substituted imidazole compounds |
| 07/17/1997 | CA2241870A1 Macrocyclic compounds made from suboxide units |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/16/1997 | EP0783518A1 Inhibitors of farnesyl-protein transferase |
| 07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
| 07/16/1997 | EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin |
| 07/16/1997 | EP0783506A1 New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use |
| 07/16/1997 | EP0783504A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE |
| 07/16/1997 | EP0783503A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO 1,2-a]PYRAZINE DERIVATIVES |
| 07/16/1997 | EP0783308A1 Use of 9-deoxy prostaglandin derivatives to treat glaucoma |
| 07/16/1997 | EP0783303A1 Use of aromatic halides for treating mammalian cell proliferation |
| 07/16/1997 | EP0728132B1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 07/16/1997 | EP0672056B1 Calcium channel blocking polypeptides from filistata hibernalis |
| 07/16/1997 | EP0632812B1 Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents |
| 07/16/1997 | EP0601154B1 Bpc peptides, their preparation and use |
| 07/16/1997 | CN1154698A Benzopyrans and their use as therapeutic agent |
| 07/16/1997 | CN1154245A Turtle oil, soft-shelled turtle oil and compositions contg. same, and the use thereof |
| 07/15/1997 | US5648492 Process for preparing isoquinoline compounds |
| 07/15/1997 | US5648387 Carboxyalkylethers, formulations, and treatment of vascular diseases |
| 07/15/1997 | US5648381 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof |
| 07/15/1997 | US5648374 Benzospiroalkene compounds |
| 07/15/1997 | US5648373 CoA-IT and PAF inhibitors |
| 07/15/1997 | US5648351 Use of macrolides for the treatment of cerebral ischemia |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/15/1997 | US5648100 Acrylamide polymers |
| 07/15/1997 | US5648076 Administering antigrowth factor antibodies following surgery |
| 07/10/1997 | WO1997024369A1 Growth-hormone secretagogues |
| 07/10/1997 | WO1997024363A1 Novel a1 adenosine receptor agonists and antagonists |
| 07/10/1997 | WO1997024353A1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 07/10/1997 | WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024342A1 Thiol derivatives with metallopeptidase inhibitory activity |
| 07/10/1997 | WO1997024334A1 Benzimidazole derivatives |
| 07/10/1997 | WO1997024135A1 Amidino protease inhibitors |
| 07/10/1997 | WO1997024124A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024122A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | WO1997024111A2 Novel hyaluronic acid receptors binding agents and the use thereof |
| 07/10/1997 | WO1997009049A3 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 07/10/1997 | DE19600301A1 Bioregulatorischer Wirkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung Bioregulatory active substance, process for its preparation and its use |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2241724A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2241414A1 Thiol derivatives with metallopeptidase inhibitory activity |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/09/1997 | EP0783002A2 Dual action inhibitors |
| 07/09/1997 | EP0782986A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/09/1997 | EP0782857A1 Remedy and preventive for nervous system disorder |
| 07/09/1997 | EP0782856A1 Carbostyril derivatives for reducing infarct size in subjects afflicted with ischemic heart disease |
| 07/09/1997 | EP0782622A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) APO(a)] |
| 07/09/1997 | EP0782574A1 Bicyclic carboxamides as 5-ht 1a? antagonists |
| 07/09/1997 | EP0782570A1 Substituted heteroaromatic compounds and their use in medicine |
| 07/09/1997 | EP0782451A1 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 07/09/1997 | CN1154107A Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/08/1997 | US5646309 Serotonin receptor antagonists; central nervous system disorders |
| 07/08/1997 | US5646308 Benzopyran derivatives |
| 07/08/1997 | US5646268 Process producing lower molecular weight range oligodeoxyribonucleotides |
| 07/08/1997 | US5646173 Tricyclic pyrrole derivatives useful as 5-HT selective agents |
| 07/08/1997 | US5646170 Tetrazole alkyl amide acat inhibitors |